In June 2009, the Science and Technology Committee of the UK House of Lords published a report on genomic medicine, based on expert evidence collected over an 18-month period. Crucially, the report signaled that the use of genomic medicine was at a crossroads, due to the rapid development of new technologies, and opened up opportunities across the whole of medicine and healthcare. This commentary responds to the report's call for a new health service strategy, including a new genetics White Paper from the Government, and suggests some of the important elements that need further consideration. ©2009 BioMed Central Ltd.
CITATION STYLE
Burton, H., Wright, C. F., & Zimmern, R. (2009, October 12). A new strategic phase for genomic medicine in UK health services. Genome Medicine. https://doi.org/10.1186/gm93
Mendeley helps you to discover research relevant for your work.